Actively Recruiting
Early Life Intervention in Pediatrics Supported by E-health
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2026-02-18
148
Participants Needed
1
Research Sites
254 weeks
Total Duration
On this page
Sponsors
I
Insel Gruppe AG, University Hospital Bern
Lead Sponsor
U
University of Bern
Collaborating Sponsor
AI-Summary
What this Trial Is About
Childhood obesity in early life contributes to the development of specific NCDs, i.e. adult obesity. Unhealthy diet and low level of physical activity are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of NCDs. Early preventive measures to improve lifestyle behavior are of utmost importance. The aim of ELIPSE-I is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering total energy intake/total energy expenditure (TEI/TEE) ratio in their children with BMI \>97 centile (ELIPSE-I).
CONDITIONS
Official Title
Early Life Intervention in Pediatrics Supported by E-health
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Parents must speak German
- Parents can be of any ethnic background or race
- Children must live and grow up in the same household as the parent participant
- Children aged 6 to 12 years with BMI above the 97th percentile based on Swiss national growth charts
- Children must attend the outpatient weight management clinic at the University Children's Hospital Bern
- Signed informed consent form must be provided by the parent(s)
You will not qualify if you...
- Children with syndromic obesity
- Children with known congenital diseases affecting musculo-skeletal, cardiac, or pulmonary function
- Children participating in another clinical trial targeting similar objectives
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Paediatrics, Inselspital, Bern University Hospital
Bern, Switzerland, 3010
Actively Recruiting
Research Team
M
Matthias V. Kopp, Prof. Dr.
CONTACT
S
Saner Christoph, PhD Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here